Vitrectomy Clinical Trial
Official title:
A Prospective, Multi-Center, Single-Dose, Phase 1 Clinical Trial Designed to Evaluate the Pharmacokinetics of Dexamethasone Phosphate Ophthalmic Solution Delivered Via the EyeGate® II Drug Delivery System in Patients Undergoing Vitrectomy for Macular Hole Repair or Epiretinal Membrane Peeling
The purpose of this study is to evaluate the pharmacokinetics (PK) of dexamethasone phosphate ophthalmic solution delivered via the EyeGate® II Drug Delivery System (EGDS) in patients undergoing vitrectomy for macular hole repair or epiretinal membrane peeling
This is an open-label, multi-center, single-dose, Phase 1 clinical trial designed to evaluate the pharmacokinetics (PK) of dexamethasone phosphate ophthalmic solution delivered via the EyeGate® II Drug Delivery System (EGDS) in the vitreous humor taken from patients undergoing vitrectomy for macular hole repair or epiretinal membrane peeling ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04409808 -
IRIS Alfa Clinical Trial A Monocentric, Academic Clinical Trial Safety Study of a Prototype of a New Vitrectomy Device.
|
N/A | |
Active, not recruiting |
NCT04566237 -
Objective Measurements of the Opacification of the Lens After Vitrectomy
|
N/A | |
Completed |
NCT00532415 -
Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy
|
Phase 3 | |
Completed |
NCT04076072 -
Beveled-Tip Versus(vs) Standard-Tip Vitrectomy Probe
|
N/A | |
Not yet recruiting |
NCT03633266 -
Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy
|
N/A | |
Completed |
NCT00927628 -
Macular Hole Reopening
|
N/A | |
Not yet recruiting |
NCT03637283 -
Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage
|
N/A | |
Completed |
NCT01255293 -
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
|
N/A | |
Terminated |
NCT01023009 -
Postoperative Evolution After Small Gauge Vitrectomy Without Eye Occlusion
|
||
Completed |
NCT00737022 -
Macular Appearance After Diabetic Vitrectomy
|
N/A | |
Completed |
NCT03902795 -
Functional and Morphological Results of Rhegmatogenous Retinal Detachment Treated With Vitrectomy
|
||
Completed |
NCT01319318 -
Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy
|
N/A | |
Not yet recruiting |
NCT04346095 -
Oral Sedation in Vitreoretinal Surgery
|
Phase 4 | |
Completed |
NCT01159665 -
The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)
|
Phase 2 | |
Completed |
NCT00685490 -
Vitrectomy for Branch Retinal Vein Occlusion
|
N/A | |
Completed |
NCT05446948 -
Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy
|
N/A | |
Completed |
NCT05710458 -
Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter
|
N/A | |
Terminated |
NCT02995746 -
Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
|
N/A | |
Completed |
NCT03701542 -
The Application of M-charts and Microperimetry for the Assessment of Visual Function in Patients After Vitrectomy Due to the Full Thickness Macular Hole.
|
||
Completed |
NCT00799227 -
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
|
Phase 2 |